Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma.

Läubli H, Balmelli C, Bossard M, Pfister O, Glatz K, Zippelius A.

J Immunother Cancer. 2015 Apr 21;3:11. doi: 10.1186/s40425-015-0057-1. eCollection 2015.

2.

Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09.

Gautschi O, Mach N, Rothschild SI, Li Q, Stahel RA, Zippelius A, Cathomas R, Früh M, Betticher DC, Peters S, Rauch D, Feilchenfeldt J, Bubendorf L, Savic S, Jaggi R, Leibundgut EO, Largiadèr C, Brutsche M, Pilop C, Stalder L, Pless M, Ochsenbein AF; Swiss Group for Clinical Cancer Research.

Clin Lung Cancer. 2015 Mar 5. pii: S1525-7304(15)00060-1. doi: 10.1016/j.cllc.2015.02.007. [Epub ahead of print]

PMID:
25843489
3.

Esterase activity of carbonic anhydrases serves as surrogate for selecting antibodies blocking hydratase activity.

Uda NR, Seibert V, Stenner-Liewen F, Müller P, Herzig P, Gondi G, Zeidler R, van Dijk M, Zippelius A, Renner C.

J Enzyme Inhib Med Chem. 2015 Mar 16:1-6. [Epub ahead of print]

PMID:
25775095
4.

Therapeutic efficacy of the F8-IL2 immunocytokine in a metastatic mouse model of lung adenocarcinoma.

Wieckowski S, Hemmerle T, Prince SS, Schlienger BD, Hillinger S, Neri D, Zippelius A.

Lung Cancer. 2015 Apr;88(1):9-15. doi: 10.1016/j.lungcan.2015.01.019. Epub 2015 Jan 31.

PMID:
25682318
5.

Cancer immunology - development of novel anti-cancer therapies.

Rothschild SI, Thommen DS, Moersig W, Müller P, Zippelius A.

Swiss Med Wkly. 2015 Feb 4;145:w14066. doi: 10.4414/smw.2015.14066. eCollection 2015.

6.

Phase diagram of selectively cross-linked block copolymers shows chemically microstructured gel.

von der Heydt A, Zippelius A.

J Chem Phys. 2015 Feb 7;142(5):054901. doi: 10.1063/1.4905831.

PMID:
25662662
7.

Induced PD-L1 expression mediates acquired resistance to agonistic anti-CD40 treatment.

Zippelius A, Schreiner J, Herzig P, Müller P.

Cancer Immunol Res. 2015 Mar;3(3):236-44. doi: 10.1158/2326-6066.CIR-14-0226. Epub 2015 Jan 26.

PMID:
25623164
8.

Cancer chemotherapy agents target intratumoral dendritic cells to potentiate antitumor immunity.

Müller P, Martin K, Theurich S, von Bergwelt-Baildon M, Zippelius A.

Oncoimmunology. 2014 Aug 3;3(8):e954460. eCollection 2014.

PMID:
25610745
9.

Vemurafenib-induced radiation recall dermatitis: case report and review of the literature.

Conen K, Mosna-Firlejczyk K, Rochlitz C, Wicki A, Itin P, Arnold AW, Gross M, Zimmermann F, Zippelius A.

Dermatology. 2015;230(1):1-4. doi: 10.1159/000365918. Epub 2014 Nov 29.

PMID:
25472806
10.

Jamming of frictional particles: a nonequilibrium first-order phase transition.

Grob M, Heussinger C, Zippelius A.

Phys Rev E Stat Nonlin Soft Matter Phys. 2014 May;89(5):050201. Epub 2014 May 27.

PMID:
25353726
11.

Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer.

Sebastian M, Papachristofilou A, Weiss C, Früh M, Cathomas R, Hilbe W, Wehler T, Rippin G, Koch SD, Scheel B, Fotin-Mleczek M, Heidenreich R, Kallen KJ, Gnad-Vogt U, Zippelius A.

BMC Cancer. 2014 Oct 6;14:748. doi: 10.1186/1471-2407-14-748.

12.

Strong dynamical heterogeneity and universal scaling in driven granular fluids.

Avila KE, Castillo HE, Fiege A, Vollmayr-Lee K, Zippelius A.

Phys Rev Lett. 2014 Jul 11;113(2):025701. Epub 2014 Jul 10.

PMID:
25062209
13.

Cetuximab in metastatic squamous cell cancer of the skin: a Swiss case series.

Conen KL, Fischer N, Hofbauer GF, Shafaeddin-Schreve B, Winterhalder R, Rochlitz C, Zippelius A.

Dermatology. 2014;229(2):97-101. doi: 10.1159/000362384. Epub 2014 Jun 7.

PMID:
24923455
14.

Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity by stimulation of dendritic cells.

Müller P, Martin K, Theurich S, Schreiner J, Savic S, Terszowski G, Lardinois D, Heinzelmann-Schwarz VA, Schlaak M, Kvasnicka HM, Spagnoli G, Dirnhofer S, Speiser DE, von Bergwelt-Baildon M, Zippelius A.

Cancer Immunol Res. 2014 Aug;2(8):741-55. doi: 10.1158/2326-6066.CIR-13-0198. Epub 2014 Apr 21.

PMID:
24916470
15.

The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity.

Martin K, Müller P, Schreiner J, Prince SS, Lardinois D, Heinzelmann-Schwarz VA, Thommen DS, Zippelius A.

Cancer Immunol Immunother. 2014 Sep;63(9):925-38. doi: 10.1007/s00262-014-1565-4. Epub 2014 Jun 7.

PMID:
24906866
16.

Active microrheology of driven granular particles.

Wang T, Grob M, Zippelius A, Sperl M.

Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Apr;89(4):042209. Epub 2014 Apr 28.

PMID:
24827243
17.

Temperature-dependent defect dynamics in the network glass SiO2.

Vollmayr-Lee K, Zippelius A.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Nov;88(5):052145. Epub 2013 Nov 27.

PMID:
24329252
18.

Antibody-based immunotherapy for ovarian cancer: where are we at?

Tse BW, Collins A, Oehler MK, Zippelius A, Heinzelmann-Schwarz VA.

Ann Oncol. 2014 Feb;25(2):322-31. doi: 10.1093/annonc/mdt405. Epub 2013 Nov 26. Review.

19.

Bundling in brushes of directed and semiflexible polymers.

Benetatos P, Terentjev EM, Zippelius A.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Oct;88(4):042601. Epub 2013 Oct 4.

PMID:
24229200
20.

Elasticity of cross-linked semiflexible biopolymers under tension.

von der Heydt A, Wilkin D, Benetatos P, Zippelius A.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Sep;88(3):032701. Epub 2013 Sep 3.

PMID:
24125288
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk